Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PRMT1 Inhibition Targets BNC1-Dependent Proliferation in Squamous Cell Carcinoma. | J Invest Dermatol | 2026 | 40962202 | PubTator, text mining | PubMed |
| Exploiting Synthetic Lethality of PRMT5 for Precision Treatment of MTAP-Deficient Glioblastoma. | Int J Transl Med (Basel) | 2025 | 42021873 | PubTator, text mining | PubMed |
| The promoting role of protein arginine methyltransferase 1 in cervical cancer: Mechanisms of angiogenesis and immune evasion. | Cytojournal | 2025 | 41664701 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms, Assessment and Therapeutics of Epidermal Stem Cells in Skin Aging. | Stem Cells Int | 2025 | 41497803 | PubTator, text mining | PubMed |
| Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axis. | NAR Cancer | 2025 | 41480640 | PubTator, text mining | PubMed |
| Genetic polymorphisms in cGAS-STING-mediated type I interferon innate immune signaling pathway are associated with DLBCL. | Front Immunol | 2025 | 41476984 | PubTator, text mining | PubMed |
| Correction: DICAR/DICAR-JP exerts therapeutic effects in brain stroke via the miR-361-5p/PRMT1 pathway. | Front Pharmacol | 2025 | 41446800 | PubTator, text mining | PubMed |
| FOSL1-PRMT1 transcriptional-epigenetic circuit promotes glioblastoma radioresistance via calcyphosine-mediated DNA repair and invasion. | Mol Biomed | 2025 | 41423530 | PubTator, text mining | PubMed |
| Knockout of protein arginine methyltransferase 1 inhibited cell growth and promoted cell migration in human bronchial epithelial cells. | Sci Rep | 2025 | 41339642 | PubTator, text mining | PubMed |
| The Identification of a Sub-Micromolar Peptide-Based Protein Arginine Methyltransferase 1 (PRMT1) Inhibitor from a Plate-Based Screening Assay. | Biomolecules | 2025 | 41301411 | PubTator, text mining | PubMed |
| PRMT1-SFPQ regulates intron retention to control matrix gene expression during craniofacial development. | bioRxiv | 2025 | 41292806 | PubTator, text mining | PubMed |
| PRMT1 drives oral squamous cell carcinoma progression by activating STAT3 and suppressing ferroptosis via GPX4. | Cell Biosci | 2025 | 41287105 | PubTator, text mining | PubMed |
| PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies. | MedComm (2020) | 2025 | 41256732 | PubTator, text mining | PubMed |
| Arginine methyltransferase PRMT1 equipoises trophoblast development to prevent early pregnancy loss. | bioRxiv | 2025 | 41256701 | PubTator, text mining | PubMed |
| Therapeutic potential of PRMT1 as a critical survival dependency target in multiple myeloma. | BMC Cancer | 2025 | 41188812 | PubTator, text mining | PubMed |
| Unlocking RAS: Finding the Right Combination Is the Key. | United European Gastroenterol J | 2025 | 41117757 | PubTator, text mining | PubMed |
| PRMT1/PRMT5-Mediated Differential Arginine Methylation of CRIP1 Promotes the Recurrence of Small Cell Lung Cancer after Chemotherapy. | Int J Biol Sci | 2025 | 41079921 | PubTator, text mining | PubMed |
| Disease-linked regulatory DNA variants and homeostatic transcription factors in epidermis. | Nat Commun | 2025 | 40998781 | PubTator, text mining | PubMed |
| Multidrug resistance reversal effect of tenacissoside I through impeding EGFR methylation mediated by PRMT1 inhibition. | Chin J Nat Med | 2025 | 40976627 | PubTator, text mining | PubMed |
| Non-canonical role of ATG4B in PRMT1-mediated DNA repair and leukemia progression. | Autophagy | 2025 | 40970672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=5